DE69520832D1 - Neurotrophische und antiproliferative verbindungen - Google Patents

Neurotrophische und antiproliferative verbindungen

Info

Publication number
DE69520832D1
DE69520832D1 DE69520832T DE69520832T DE69520832D1 DE 69520832 D1 DE69520832 D1 DE 69520832D1 DE 69520832 T DE69520832 T DE 69520832T DE 69520832 T DE69520832 T DE 69520832T DE 69520832 D1 DE69520832 D1 DE 69520832D1
Authority
DE
Germany
Prior art keywords
neurotrophic
antiproliferative
connections
compounds
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520832T
Other languages
English (en)
Other versions
DE69520832T2 (de
Inventor
M Regan
Heinz Nau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Dublin
American Biogenetic Sciences Inc
Original Assignee
University College Dublin
American Biogenetic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26970481&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69520832(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/298,108 external-priority patent/US5672746A/en
Application filed by University College Dublin, American Biogenetic Sciences Inc filed Critical University College Dublin
Application granted granted Critical
Publication of DE69520832D1 publication Critical patent/DE69520832D1/de
Publication of DE69520832T2 publication Critical patent/DE69520832T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/18—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Farming Of Fish And Shellfish (AREA)
DE69520832T 1994-08-30 1995-08-25 Neurotrophische und antiproliferative verbindungen Expired - Fee Related DE69520832T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/298,108 US5672746A (en) 1994-08-30 1994-08-30 Antiproliferative and neurotrophic molecules
US08/446,481 US6300373B1 (en) 1993-09-10 1995-05-22 Antiproliferative and neurotrophic molecules
PCT/US1995/010775 WO1996006821A1 (en) 1994-08-30 1995-08-25 Neurotrophic and antiproliferative compounds

Publications (2)

Publication Number Publication Date
DE69520832D1 true DE69520832D1 (de) 2001-06-07
DE69520832T2 DE69520832T2 (de) 2001-08-09

Family

ID=26970481

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520832T Expired - Fee Related DE69520832T2 (de) 1994-08-30 1995-08-25 Neurotrophische und antiproliferative verbindungen

Country Status (14)

Country Link
US (3) US6300373B1 (de)
EP (1) EP0778820B1 (de)
JP (2) JP3914568B2 (de)
AT (1) ATE200890T1 (de)
AU (1) AU3415195A (de)
CA (1) CA2198728A1 (de)
DE (1) DE69520832T2 (de)
DK (1) DK0778820T3 (de)
ES (1) ES2158124T3 (de)
GR (1) GR3036294T3 (de)
HK (1) HK1008882A1 (de)
NZ (2) NZ334119A (de)
PT (1) PT778820E (de)
WO (1) WO1996006821A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300373B1 (en) * 1993-09-10 2001-10-09 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
EP1170008A1 (de) * 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Valproinsäure und dessen Derivate als Inhibitoren der Histone deacetylase
EP1293205A1 (de) * 2001-09-18 2003-03-19 G2M Cancer Drugs AG Valproinsäure und deren Derivate zur Kombinationsbehandlung von Krebs beim Menschen und zur Behandlung von Tumor-Metastasen und minimaler Resterkrankung
WO2003048301A2 (en) * 2001-10-11 2003-06-12 Protein Design Labs Inc. Anti-hla-dr antibodies and the methods of using thereof
AU2003289782A1 (en) * 2002-12-16 2004-07-09 The University Of British Columbia Valproic acid analogues and pharmaceutical compositions thereof
WO2007075077A1 (es) * 2005-11-16 2007-07-05 Universidad Nacional Autonoma De Mexico Uso de agentes modificantes del transcriptoma más quimioterapia o radioterapia contra el cáncer
BRPI0717972A2 (pt) * 2006-11-01 2013-11-12 Pronova Biopharma Norge As Lipídeos de ômega-3 alfa-substituídos que são ativadores ou moduladores do receptor ativado por proliferadores de peroxissoma (ppar)
ES2342997B1 (es) * 2008-12-09 2011-06-06 Universitat De Les Illes Balears Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1066578B (de) 1959-10-08 Dr. rer. nat. Karl Ernst Schulte, Berlin - Dahlem Verfahren zur Herstellung von ungesättigten Lactonen
FR2442M (fr) 1962-10-17 1964-04-06 Henry Eugene L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central.
GB1051322A (de) * 1967-08-09
US3701729A (en) 1970-06-01 1972-10-31 Tenneco Chem Oil-soluble mixed copper soap products
US3847956A (en) 1973-04-06 1974-11-12 Us Agriculture 2-hydroperoxycarboxylic acids and their preparation
US3932285A (en) 1973-10-03 1976-01-13 Tenneco Chemicals, Inc. Chromium salt compositions and a process for their production
US4025649A (en) 1974-08-19 1977-05-24 Labaz Acetic acid derivatives having pharmacological activity and compositions containing the same
US4129599A (en) 1975-04-28 1978-12-12 The Board Of Trustees Of Leland Stanford Jr. University A-Norsteroids
JPS5650116A (en) 1979-09-27 1981-05-07 Tohoku Electric Power Co Inc Manufacture of calcined gypsum
JPS5680116A (en) 1979-12-05 1981-07-01 Sanyo Electric Co Ltd Manufacture of substrate for magnetic bubble
JPH0233704B2 (ja) 1982-10-07 1990-07-30 Takeda Chemical Industries Ltd Chikanbinirukarubonsanjudotai
FR2599737B1 (fr) 1986-06-10 1989-05-19 Sanofi Sa Procede pour la fixation de groupes alkyles, alkenyles, cycloalkyles ou aralkyles sur une chaine carbonee portant un groupement fonctionnel
JPH01135740A (ja) 1987-11-24 1989-05-29 Nippon Mining Co Ltd 光学活性を有する２―アルキル―１―アルカン酸の製造方法
US5021398A (en) 1989-10-26 1991-06-04 Amp Incorporated Method of forming patterned oxide superconducting films
DE4231085A1 (de) * 1992-09-12 1994-03-17 Desitin Arzneimittel Gmbh VPA-analoge Antiepileptika
AU5678194A (en) 1992-11-30 1994-06-22 Procter & Gamble Company, The High sudsing detergent compositions with specially selected soaps
JP3304459B2 (ja) 1992-12-18 2002-07-22 松下電器産業株式会社 電解コンデンサ駆動用電解液およびそれを用いた電解コンデンサ
ATE163006T1 (de) 1993-06-01 1998-02-15 Ono Pharmaceutical Co Pentansäurederivate
US6300373B1 (en) * 1993-09-10 2001-10-09 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
WO1995033044A1 (en) 1994-05-27 1995-12-07 The Procter & Gamble Company Liquid laundry detergent compositions comprising specially selected soaps

Also Published As

Publication number Publication date
DE69520832T2 (de) 2001-08-09
CA2198728A1 (en) 1996-03-07
EP0778820B1 (de) 2001-05-02
ES2158124T3 (es) 2001-09-01
US20020013367A1 (en) 2002-01-31
EP0778820A1 (de) 1997-06-18
MX9701594A (es) 1998-07-31
NZ334119A (en) 2000-09-29
JP2007091748A (ja) 2007-04-12
AU3415195A (en) 1996-03-22
US6274624B1 (en) 2001-08-14
HK1008882A1 (en) 1999-05-21
ATE200890T1 (de) 2001-05-15
US6300373B1 (en) 2001-10-09
JP3914568B2 (ja) 2007-05-16
WO1996006821A1 (en) 1996-03-07
JPH10505064A (ja) 1998-05-19
NZ292388A (en) 1999-03-29
GR3036294T3 (en) 2001-10-31
PT778820E (pt) 2001-10-31
DK0778820T3 (da) 2001-08-20

Similar Documents

Publication Publication Date Title
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
DE69534130D1 (de) Verbindungen zur behandlung von erkrankungen,die mit des vasculogenese und/oder angiogenese in verbunden stehen.
DE69513976T2 (de) Entzündungshemmende verbindungen
ITMI930699A1 (it) Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
DE69106996D1 (de) Gesockelte Hochdruckentladungslampe und Lampenfassung für diese Lampe.
DE3882642D1 (de) Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten.
DE69520832T2 (de) Neurotrophische und antiproliferative verbindungen
TR199901101T2 (xx) Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
DE69212289D1 (de) Metallsulfate als Flockungsmittel für die Abwasserreinigung und ihre Herstellung
ATE132149T1 (de) Konjugate von difluoroglutaminsäure mit fölaten und antifölaten für die behandlung von neoplastischen krankheiten
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
DE69327812D1 (de) Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
NO974569D0 (no) Benzamider for behandling av neurodegenerative forstyrrelser
FR2692606B1 (fr) Machine pour le traitement du lit de ballast.
DE69009765T2 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE59410056D1 (de) Arzneimittel zur Behandlung der Sepsis und des septischen Schocks
NO972348D0 (no) Behandlingsanlegg for bioavfall
DE9410664U1 (de) Be- oder Entlüftungsvorrichtung für die Behandlung von Abfallprodukten
IT1280629B1 (it) Tripeptide per il trattamento delle forme cancerose, in particolare per il trattamento del melanoma.
RU98103406A (ru) Способ лечения вибрационной болезни
ES1008816Y (es) Difusor perfeccionado para depuradoras de aguas residuales.
RU98112366A (ru) Препарат для лечения зудящих заболеваний
RU95111889A (ru) Способ местной анестезии в отиатрии
ITMI952488A1 (it) Composizioni farmaceutiche utili nel trattamento del dismetabolismo osseo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee